The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: -4.50 (-1.16%)
Spread: 2.00 (0.515%)
Open: 392.50
High: 393.00
Low: 383.50
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to listing of the new shares

28 Jul 2017 16:40

RNS Number : 4901M
Banco Santander S.A.
28 July 2017
 

 

MATERIAL FACT

Further to the material fact announcement published yesterday (registration number 255,167) in connection with the closing and registration with the Commercial Registry of Cantabria of the share capital increase with preemptive subscription rights of Banco Santander, S.A. ("Banco Santander"), which share securities note of the Spanish informative prospectus was registered with the official registry of the Comisión Nacional del Mercado de Valores on 4 July 2017 (the "Capital Increase"), Banco Santander informs that:

- Today the Comisión Nacional del Mercado de Valores has confirmed that the applicable requirements for the listing of the 1,458,232,745 new shares with a nominal value of fifty euro cents each resulting from the Capital Increase are met and the Spanish Stock Exchanges Governing Bodies have approved the admission to listing of the new shares.

- The new shares are expected to be listed on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges through the Spanish Automated Quotation System (Mercado Continuo) on 31 July 2017.

 

Boadilla del Monte (Madrid), 28 July 2017

 

 

 

IMPORTANT INFORMATION

 

The present announcement is not an informative prospectus but an informative communication and investors should not subscribe any new shares of Banco Santander, S.A. ("Banco Santander" or the "Bank") or purchase any pre-emptive subscription rights for new shares of the Bank's Capital Increase referred to herein except on the basis of the information contained in the prospectus in connection with the capital increase which has been registered with the Comisión Nacional del Mercado de Valores ("CNMV") on 4 July 2017 and is publicly available at the Bank's registered address and, in electronic format, in the web pages of the Bank (www.santander.com) and the CNMV (www.cnmv.es). Likewise, the Bank obtained on 5 July 2017 the community passport of the informative prospectus for the purposes of it being cross-border effective in the United Kingdom, Italy, Portugal and Poland.

 

This communication does not constitute an offer to sell, or a solicitation of offers to subscribe, the pre-emptive subscription rights or the new shares of the share capital increase in any jurisdiction in which such offer or solicitation is unlawful or, as the case may be, until the applicable requirements for those purposes have been met. The distribution of this communication and/or the prospectus and/or the transfer of pre-emptive subscription rights and/or new shares into jurisdictions other than Spain, the United Kingdom, Italy, Portugal and Poland may be restricted by law. Persons who gain access to the information set out herein should be aware of and comply with any such restrictions. Any failure to comply with them may constitute a breach of the securities laws of any such jurisdiction.

 

This communication (i) must not be construed in any way to be a request to buy or to sell securities or any related financial instruments in Brazil, and (ii) must not be construed in any way to be a public offering of securities in Brazil. The Brazilian Securities Commission (Comissão de Valores Mobiliários) has not authorised the public offering of shares to which this communication refers nor of any securities related to such shares. Hence, the said shares cannot be offered to the public in Brazil.

 

The Bank has filed a registration statement (including a prospectus) with the SEC for the capital increase and the offering of new shares and subscription rights to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the prospectus supplement and any other documents the Bank has filed, or may file, with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, you may obtain a copy of the prospectus from Citigroup by calling toll free 1-800-831-9146 or UBS by calling toll free 1-877-387-2275.

 

The public offering of the new Banco Santander shares has been authorised by the Argentine National Securities Commission, and the Subscription Announcement (Aviso de Suscripción) setting forth the procedure and term for the subscription for new shares in Argentina has already been published in such jurisdiction. The capital increase to which this announcement refers and the Argentine offering will have the same terms and conditions, save as otherwise provided in the relevant Subscription Announcement. The Bank envisages to request the admission to trading of the new shares in the Buenos Aires stock exchange.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSPGUQWMUPMGAR
Date   Source Headline
12th Dec 202211:06 amRNSTransaction in Own Shares
12th Dec 20227:00 amRNSDirectorate Change
1st Dec 20225:20 pmRNSBuyback programme: transactions 22 - 30 November
30th Nov 20226:20 pmRNSTotal Voting Rights
21st Nov 20222:07 pmRNSCommencement of a program to repurchase own shares
26th Oct 202211:09 amRNSForm 8.3 - HomeServe Plc
26th Oct 20227:00 amRNS3rd Quarter 2022 Results
26th Oct 20227:00 amRNS3rd Quarter 2022 Results - Press release
21st Oct 20227:00 amRNSTender Offer
19th Oct 20223:04 pmRNSNotice of Third Quarter 2022 Results
27th Sep 20226:19 pmRNSDividend Declaration
27th Sep 20225:16 pmRNSHalf-year Report
22nd Sep 20228:36 amRNSForm 8.3 - HomeServe plc
30th Aug 20227:36 amRNSForm 8.3 - Meggitt plc
4th Aug 202211:50 amRNSDirector/PDMR Shareholding
28th Jul 20227:13 amRNS1H2022 results report & analyst presentation
28th Jul 20227:00 amRNSFirst half 2022 results press release
27th Jul 20223:02 pmRNSNotice of First Half 2022 Results
22nd Jul 20227:04 amRNSCitigroup, Inc. process in Mexico
8th Jul 20227:00 amRNSInformation to bondholders
1st Jul 20222:09 pmRNSFurther re Capital reduction
30th Jun 20226:41 pmRNSTotal Voting Rights
29th Jun 202211:16 amRNSRedemption and cancellation of territorial bonds
28th Jun 20225:24 pmRNSCapital Reduction (2022 buy-back programme shares)
17th Jun 20229:38 amRNSDirectorate Change (Conference call)
17th Jun 20227:00 amRNSDirectorate Change
13th Jun 20223:26 pmRNSDirector/PDMR Shareholding
10th Jun 202211:34 amRNSTotal redemption and cancellation of covered bonds
6th Jun 20227:00 amRNSTotal redemption and cancellation of covered bonds
20th May 202212:19 pmRNSSantander informs of the MREL determined by SRB
6th May 20223:29 pmRNSEnd of the Programme & 28 Apr - 6 May Transactions
6th May 20222:48 pmRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSTotal Voting Rights
29th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Apr 20229:40 amRNSDirector/PDMR Shareholding
28th Apr 202211:12 amRNSBuyback programme: transactions 19 - 27 April
26th Apr 20224:54 pmRNSFurther re Capital reduction
26th Apr 20227:00 amRNS1Q2022 results report & analyst presentation
26th Apr 20227:00 amRNS1st Quarter 2022 Results - Press release
25th Apr 20223:04 pmRNSNotice of First Quarter 2022 Results
21st Apr 202211:48 amRNSForm 8.3 - Meggitt plc
19th Apr 202211:43 amRNSTransaction in Own Shares
7th Apr 202211:41 amRNSBuyback programme: transactions 31 March - 6 April
4th Apr 20225:39 pmRNSNew financial reporting
1st Apr 20225:57 pmRNSCapital reduction (2021 buy-back programme shares)
1st Apr 20224:30 pmRNS2022 AGM - Resolutions
1st Apr 20227:00 amRNSSantander confirms its financial targets for 2022
1st Apr 20227:00 amRNS2021 UK Annual Report
31st Mar 202211:33 amRNSBuyback programme: transactions 24 - 30 March
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.